Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

The ascent of pulmonary drug delivery.

Gonda I.

J Pharm Sci. 2000 Jul;89(7):940-5. Review.

PMID:
10861595
2.

Systemic delivery of drugs to humans via inhalation.

Gonda I.

J Aerosol Med. 2006 Spring;19(1):47-53. Review.

PMID:
16551214
3.

Pulmonary delivery of insulin by liposomal carriers.

Huang YY, Wang CH.

J Control Release. 2006 Jun 12;113(1):9-14. Epub 2006 Mar 28.

PMID:
16730838
4.

Treating systemic diseases via the lung.

Sanjar S, Matthews J.

J Aerosol Med. 2001;14 Suppl 1:S51-8. Review.

PMID:
11424894
5.

Miniature inhalation therapy platform using surface acoustic wave microfluidic atomization.

Qi A, Friend JR, Yeo LY, Morton DA, McIntosh MP, Spiccia L.

Lab Chip. 2009 Aug 7;9(15):2184-93. doi: 10.1039/b903575c. Epub 2009 May 14.

PMID:
19606295
6.
7.

Pulmonary drug delivery: medicines for inhalation.

Henning A, Hein S, Schneider M, Bur M, Lehr CM.

Handb Exp Pharmacol. 2010;(197):171-92. doi: 10.1007/978-3-642-00477-3_6. Review.

PMID:
20217530
8.

The lungs as a portal of entry for systemic drug delivery.

Patton JS, Fishburn CS, Weers JG.

Proc Am Thorac Soc. 2004;1(4):338-44. Review.

PMID:
16113455
9.

Clinical perspectives on pulmonary systemic and macromolecular delivery.

Scheuch G, Kohlhaeufl MJ, Brand P, Siekmeier R.

Adv Drug Deliv Rev. 2006 Oct 31;58(9-10):996-1008. Epub 2006 Aug 12. Review.

PMID:
16996638
10.

Drug delivery via the respiratory tract.

Byron PR, Patton JS.

J Aerosol Med. 1994;7(1):49-75.

PMID:
10147058
11.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
12.

The inhalation of drugs: advantages and problems.

Rau JL.

Respir Care. 2005 Mar;50(3):367-82.

13.

Strategies for non-invasive delivery of biologics.

Chung SW, Hil-lal TA, Byun Y.

J Drug Target. 2012 Jul;20(6):481-501. doi: 10.3109/1061186X.2012.693499. Epub 2012 May 28. Review.

PMID:
22632037
14.

Pulmonary drug delivery: from generating aerosols to overcoming biological barriers-therapeutic possibilities and technological challenges.

Ruge CA, Kirch J, Lehr CM.

Lancet Respir Med. 2013 Jul;1(5):402-13. doi: 10.1016/S2213-2600(13)70072-9. Epub 2013 Jun 4. Review.

PMID:
24429205
15.

Recent advances in pulmonary drug delivery using large, porous inhaled particles.

Edwards DA, Ben-Jebria A, Langer R.

J Appl Physiol (1985). 1998 Aug;85(2):379-85. Review.

16.

Passive lung-targeted drug delivery systems via intravenous administration.

Wei Y, Zhao L.

Pharm Dev Technol. 2014 Mar;19(2):129-36. doi: 10.3109/10837450.2012.757782. Epub 2013 Jan 22. Review.

PMID:
23336716
17.

Targeted delivery of magnetic aerosol droplets to the lung.

Dames P, Gleich B, Flemmer A, Hajek K, Seidl N, Wiekhorst F, Eberbeck D, Bittmann I, Bergemann C, Weyh T, Trahms L, Rosenecker J, Rudolph C.

Nat Nanotechnol. 2007 Aug;2(8):495-9. doi: 10.1038/nnano.2007.217. Epub 2007 Jul 22.

PMID:
18654347
18.

Recent advances in liposomal dry powder formulations: preparation and evaluation.

Misra A, Jinturkar K, Patel D, Lalani J, Chougule M.

Expert Opin Drug Deliv. 2009 Jan;6(1):71-89. doi: 10.1517/17425240802652309 . Review.

PMID:
19236209
19.

[Local and systemic delivery of high-molecular weight drugs by powder inhalation].

Okamoto H, Danjo K.

Yakugaku Zasshi. 2007 Apr;127(4):643-53. Review. Japanese.

20.

Aerosols for systemic delivery of macromolecules.

Newhouse MT, Corkery KJ.

Respir Care Clin N Am. 2001 Jun;7(2):261-75, vi. Review.

PMID:
11517023

Supplemental Content

Support Center